Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Drug Name | Debio 4126 |
Trade Name | |
Synonyms | Debio-4126|Debio4126 |
Drug Descriptions |
Debio 4126 comprises the somatostatin analog octreotide formulated for sustained release, which potentially activates somatostatin receptors leading to decreased angiogenesis and tumor cell proliferation, and increased tumor cell death (NCI Drug Dictionary). |
DrugClasses | |
CAS Registry Number | NA |
NCIT ID | C187656 |
Therapy Name | Drugs | Efficacy Evidence | Clinical Trials |
---|---|---|---|
Debio 4126 | Debio 4126 | 0 | 0 |
Debio 4126 + Lanreotide acetate | Debio 4126 Lanreotide acetate | 0 | 1 |
Debio 4126 + Octreotide acetate | Debio 4126 Octreotide acetate | 0 | 1 |